Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience.

MLA

Varricchi, Gilda, et al. “Mepolizumab in the Management of Severe Eosinophilic Asthma in Adults: Current Evidence and Practical Experience.” Therapeutic Advances in Respiratory Disease, vol. 11, no. 1, Jan. 2017, pp. 40–45. EBSCOhost, https://doi.org/10.1177/1753465816673303.

APA

Varricchi, G., Bagnasco, D., Ferrando, M., Puggioni, F., Passalacqua, G., & Canonica, G. W. (2017). Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience. Therapeutic Advances in Respiratory Disease, 11(1), 40–45. https://doi.org/10.1177/1753465816673303

Chicago

Varricchi, Gilda, Diego Bagnasco, Matteo Ferrando, Francesca Puggioni, Giovanni Passalacqua, and Giorgio W Canonica. 2017. “Mepolizumab in the Management of Severe Eosinophilic Asthma in Adults: Current Evidence and Practical Experience.” Therapeutic Advances in Respiratory Disease 11 (1): 40–45. doi:10.1177/1753465816673303.